GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.03M | 1.60M | 1.02M | 1.41M | 1.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.66M | 3.37M | 2.90M | 3.05M | 1.95M |
| Operating Income | -2.66M | -3.37M | -2.90M | -3.05M | -1.95M |
| Income Before Tax | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M |
| EBIT | -2.66M | -3.37M | -2.90M | -3.05M | -1.95M |
| EBITDA | -2.66M | -3.36M | -2.90M | -3.05M | -1.95M |
| EPS Basic | -13.25 | -35.88 | -36.72 | -162.31 | -220.02 |
| Normalized Basic EPS | -8.28 | -22.42 | -22.95 | -101.45 | -69.42 |
| EPS Diluted | -13.25 | -35.88 | -36.72 | -162.31 | -220.02 |
| Normalized Diluted EPS | -8.28 | -22.42 | -22.95 | -101.45 | -69.42 |
| Average Basic Shares Outstanding | 200.70K | 93.60K | 78.80K | 18.80K | 17.50K |
| Average Diluted Shares Outstanding | 200.70K | 93.60K | 78.80K | 18.80K | 17.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |